Clinical and Statistical Support Core/Loyd
临床和统计支持核心/Loyd
基本信息
- 批准号:8401046
- 负责人:
- 金额:$ 47.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:BMPR2 geneBiopsyBloodBlood PressureCalendarCell Culture TechniquesCellsCessation of lifeClinicalClinical DataClinical ResearchClinical TrialsCollaborationsCollectionCommunicationComputer softwareCountryDNADataData AnalysesData CollectionData QualityData SetDatabasesDefectDevelopmentDiseaseDoctor of PhilosophyEnrollmentEpidemiologistFamilyFibroblastsFundingGeneticGenomicsHeart failureHormonalHumanHuman ResourcesIceInstructionInternetInterventionLaboratoriesLocationLogicLungMaintenanceMetabolicMethodsMolecularMonitorOnline SystemsOutcomeOutcome MeasurePatient RecruitmentsPatientsPhenotypePlasmaProceduresProcessProgram Research Project GrantsProtocols documentationPulmonary CirculationQuality ControlRNARecording of previous eventsRecruitment ActivityReportingResearch PersonnelResearch Project GrantsResourcesReview CommitteeRoleRunningSafetySample SizeSamplingScheduleSecureSignal TransductionSkinSpecimenStreamSurveysTestingTissue SampleTissuesUnited States National Institutes of HealthUniversitiesUrineVascular Diseasesbasecohortdata acquisitiondata managementdatabase designdesigneffective therapyfamily geneticshuman datamedical examinationmutation carrierpatient populationpulmonary arterial hypertensionreconstitutionrepositoryresearch studysample collectiontool
项目摘要
CORE B: This Core supports the Projects in this application through three functions. These are: Function 1) to coordinate recruitment of PAH patients and controls, clinically evaluate enrollees and conduct sample collection; Function 2) establish and maintain a biospecimen repository and distribute its resources (serum, plasma, circulating cells, cultured fibroblasts, DNA, RNA, banked tissue samples) to Projects 1, 2 and 3 and
to collaborators at Columbia and for other NIH funded investigators; Function 3) facilitate analysis of data, especially human data in Projects 1, 2 and 3. The idiopathic PAH patients will largely be drawn from our Center for Pulmonary Vascular Disease, a clinical center that has nearly 450 reference patients and has successfully participated in over 20 national clinical trials over the last decade. Controls will come from the Vanderbilt General Clinical Research Center bank (ResearchMatch.com) and from within families. We use a
national specimen and survey company for offsite collection of specimens. HPAH patients will also be recruited from Columbia University through an ongoing collaboration with Dr. Wendy Chung who runs the PH genetics component of the Columbia PH group. In Function 2, blood, urine, fibroblasts, cells, DNA, RNA and tissue will be generated, processed and stored in the laboratories of the Pulmonary Circulation Genomics
Center, the Vanderbilt DNA Resource Core and the laboratories of the Pulmonary Division. Management of the entire collection will be done by dedicated personnel using the comprehensive REDCap data base. We have a history of over 2 thousand total subjects in our database, including the Progeny Software used for genetic and family data, and can move DNA, RNA, data and materials reliably and accurately. Function 3 is
the analysis of data created largely in Projects 1 and 2. The development and design of experiments has been aided by our Epidemiologist and Statistician who will be the statistical coordinator for the entire PPG, including powering, sample size, estimates, outcome measures, data check and quality control, application of appropriate biostatlstical tests depending on data sets and hypotheses. Thus statistical support is fully
integrated into the design, conduct and analysis.
CORE B:这个CORE通过三个功能支持这个应用程序中的项目。功能1)协调PAH患者和对照组的招募,临床评估入组者并进行样本采集;功能2)建立和维护生物标本库,并将其资源(血清、血浆、循环细胞、培养成纤维细胞、DNA、RNA、储存组织样本)分配给项目1、2和3
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ivan M Robbins其他文献
Ivan M Robbins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ivan M Robbins', 18)}}的其他基金
IXth International Pulmonary Hypertension Conference: Scientific Sessions
第九届国际肺动脉高压会议:科学会议
- 批准号:
8007167 - 财政年份:2010
- 资助金额:
$ 47.41万 - 项目类别:
A PILOT STUDY COMPARING ANTI-PLATELET THERAPIES AND PLACEBO IN PULMONARY ARTE
比较肺动脉疾病中抗血小板疗法和安慰剂的试点研究
- 批准号:
7207236 - 财政年份:2004
- 资助金额:
$ 47.41万 - 项目类别:
Evaluation of Circulating Lipid and Protein Mediators in Patients
患者循环脂质和蛋白质介质的评估
- 批准号:
7041377 - 财政年份:2003
- 资助金额:
$ 47.41万 - 项目类别:
A pilot study comparing anti-platelet therapies and placebo in pulmonary arte...
一项比较抗血小板疗法和安慰剂治疗肺动脉疾病的初步研究...
- 批准号:
7041425 - 财政年份:2003
- 资助金额:
$ 47.41万 - 项目类别:
Mentored Patient-Oriented Research Career Development Aw
指导以患者为中心的研究职业发展Aw
- 批准号:
6033387 - 财政年份:2000
- 资助金额:
$ 47.41万 - 项目类别:
Mentored Patient-Oriented Research Career Development Aw
指导以患者为中心的研究职业发展Aw
- 批准号:
6639888 - 财政年份:2000
- 资助金额:
$ 47.41万 - 项目类别:
Mentored Patient-Oriented Research Career Development Aw
指导以患者为中心的研究职业发展Aw
- 批准号:
6540670 - 财政年份:2000
- 资助金额:
$ 47.41万 - 项目类别:
Mentored Patient-Oriented Research Career Development Aw
指导以患者为中心的研究职业发展Aw
- 批准号:
6754466 - 财政年份:2000
- 资助金额:
$ 47.41万 - 项目类别:
Mentored Patient-Oriented Research Career Development Aw
指导以患者为中心的研究职业发展Aw
- 批准号:
6394798 - 财政年份:2000
- 资助金额:
$ 47.41万 - 项目类别:
相似海外基金
Optimizing blood biopsy in cancers with low mutation burden and high structural complexity
优化突变负荷低、结构复杂性高的癌症的血液活检
- 批准号:
10789700 - 财政年份:2023
- 资助金额:
$ 47.41万 - 项目类别:
L2M NSERC - A liquid biopsy blood test for breast cancer detection
L2M NSERC - 用于乳腺癌检测的液体活检血液测试
- 批准号:
576550-2022 - 财政年份:2022
- 资助金额:
$ 47.41万 - 项目类别:
Idea to Innovation
Liquid biopsy for Rhabdoid tumor by Exoxomal-microRNAs in blood and other body fluids
利用血液和其他体液中的 Exoxomal-microRNA 对横纹肌样瘤进行液体活检
- 批准号:
21K07778 - 财政年份:2021
- 资助金额:
$ 47.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
- 批准号:
10634540 - 财政年份:2021
- 资助金额:
$ 47.41万 - 项目类别:
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
- 批准号:
10421266 - 财政年份:2021
- 资助金额:
$ 47.41万 - 项目类别:
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
- 批准号:
10844821 - 财政年份:2021
- 资助金额:
$ 47.41万 - 项目类别:
Implication search for peripheral blood circulation cancer cellsas a Liquid biopsy target
外周血循环癌细胞作为液体活检目标的意义研究
- 批准号:
21H03021 - 财政年份:2021
- 资助金额:
$ 47.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Monitoring of residual and recurrence of cervical cancer after radiotherapy using blood liquid biopsy.
使用血液活检监测放疗后宫颈癌的残留和复发。
- 批准号:
20K08106 - 财政年份:2020
- 资助金额:
$ 47.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of a Novel Liquid Biopsy Technique for Colorectal Cancer Using MicroRNA Editing in Blood
利用血液中的 MicroRNA 编辑建立结直肠癌新型液体活检技术
- 批准号:
20K22848 - 财政年份:2020
- 资助金额:
$ 47.41万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Prediction of colorectal cancer using liquid biopsy of the blood in surgically resected specimen
利用手术切除标本中血液的液体活检预测结直肠癌
- 批准号:
19K09127 - 财政年份:2019
- 资助金额:
$ 47.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)